Vaivos šypsena, MB - financials and debts

Company age: 2 y. 9 mo.

Update

Vaivos šypsena - Company finances

EUR
2023
From: 2023-12-07
To: 2023-12-31
2024
From: 2024-01-01
To: 2024-12-31
2025
From: 2025-01-01
To: 2025-12-31
Financial data
Sales revenue - 205,416 195,173
Profit before tax 0 131,587 63,613
Net profit 0 125,977 53,556
Equity 10 11,987 25,153
Liabilities 0 10,243 41,596
Non-current assets 0 0 0
Current assets 10 22,230 66,749
Total assets 10 22,230 66,749
Taxes paid
STI taxes - 135 5,011
Financial indicators
Revenue change y/y - - -5.0%
ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. 0.0% 566.7% 80.2%
ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. 0.0% 1050.9% 212.9%
Profit margin Net profit margin. Shows the overall profitability of the company. - 61.3% 27.4%
EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. - 64.1% 32.6%
Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. - 0.9 1.7
Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. - - -

Purchase full financial statements

Profit/Loss, Balance Sheet, Cash Flow, Equity

9.99 € + PVM Buy

See Scoris data in Google Search

Mark Scoris as a favorite source. One click, no registration.

Vaivos šypsena - Social security debts

The company had no debts to Sodra

Vaivos šypsena - VMI tax arrears

As of 2026-09-17, the amount of overdue STI tax debt of the company Vaivos šypsena is: 3 €

From To Overdue, €
2026-07-01 2026-09-17 2.72
2026-02-21 2026-03-02 2.0

VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.

Analysis of the company's financial position

This description was generated by artificial intelligence. Report if inaccurate.
Vaivos šypsena, MB (company code 306641286) is a small partnership operating in intermediation service activities for medical, dental and other human health services. In the latest financial year, 2025, the company generated revenue of €195.2K and net profit of €53.6K, corresponding to a profit margin of 27.4%. Revenue decreased by 5.0% year on year from €205.4K in 2024, while net profit also declined from €126.0K, indicating a softer but still profitable operating year. Over the two reported years, the company moved from a very high-margin result in 2024 to a lower, though still solid, margin in 2025. At the end of 2025, total assets stood at €66.7K, equity at €25.2K and liabilities at €41.6K. The equity ratio was 37.7% and debt-to-equity was 1.65x, showing a moderate leverage position. Asset turnover reached 2.92x, reflecting efficient use of the asset base. Returns remained strong in 2025.